Diffuse alveolar hemorrhage with pseudoprogression during nivolumab therapy in a patient with malignant melanoma

Nivolumab, an anti‐PD‐1 antibody, has been shown to be effective in many cancers, such as malignant melanoma and lung cancer; however, nivolumab therapy can result in pseudoprogression. Diffuse alveolar hemorrhage (DAH) is persistent or recurrent pulmonary hemorrhage as a result of drugs, autoimmune...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Ikeda, Takaya, Yamaguchi, Hiroyuki, Dotsu, Yosuke, Taniguchi, Hirokazu, Gyoutoku, Hiroshi, Senju, Hiroaki, Sakamoto, Noriho, Iwanaga, Satoshi, Kuwatsuka, Yutaka, Fukuda, Minoru, Mukae, Hiroshi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2018
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6209794/
https://ncbi.nlm.nih.gov/pubmed/30253076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12872
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados